Member

There absolutely are scientific research reasons for doing that, and it is done from a very tricky position; but of course, the pharmaceutical companies would do it for the commercial benefit, because if you can find a cure or something to ameliorate the progression of dementia, that would obviously be incredibly valuable. It is about getting that balance right.